Drugs / mix vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02338752 Comparator | Jan → Aug 2015 | pancreatic neoplasm | Fuda Cancer Hospital, Guangzhou | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mix vaccine | “The purpose of this study is to evaluate the safeness and effectiveness of mix vaccine (MV).” NCT02338752 ↗ |
| Known as | MV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02338752 ↗ |
| Modality | Vaccine | “simultaneous standard therapy and injection of mix vaccine (MV)” NCT02338752 ↗ |
| Route | Subcutaneous | “Inject 0.5 ml of the mixture subcutaneously every week.” NCT02338752 ↗ |